1-1 of 1
Davide Dalu, MD
Close
Sort by
Journal Articles

TARC Is Useful as Additional Prognostic Factor for Hodgkin's Lymphoma Outcome.

Simonetta Viviani, MD, Arabella Mazzocchi, Valeria Bonfante, Rosalba Miceli, MD, Davide Dalu, MD, Marina Galbiati, Fernando Ravagnani, Luigi Mariani, Alessandro Massimo Gianni
Journal: Blood
Blood (2009) 114 (22): 1557.
https://doi.org/10.1182/blood.V114.22.1557.1557
Published: 2009